Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy
- Xiuting Liu
- , John M. Baer
- , Meredith L. Stone
- , Brett L. Knolhoff
- , Graham D. Hogg
- , Madeleine C. Turner
- , Yu Lan Kao
- , Alyssa G. Weinstein
- , Faiz Ahmad
- , Jie Chen
- , Andrew D. Schmidt
- , Jeffrey A. Klomp
- , Heather Coho
- , Kayjana S. Coho
- , Silvia Coma
- , Jonathan A. Pachter
- , Kirsten L. Bryant
- , Liang I. Kang
- , Kian Huat Lim
- , Gregory L. Beatty
- Section of Medical Oncology
- Division of Anatomic and Molecular Pathology (AMP)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Molecular Oncology & Developmental Therapeutics
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- Bursky Center for Human Immunology and Immunotherapy
- Division of Oncology
Research output: Contribution to journal › Article › peer-review
20
Link opens in a new tab
Scopus
citations